Remove 2001 Remove Biosimilars Remove Pharmaceutical Companies
article thumbnail

Psychedelic medicines: are they gaining traction in Europe?

European Pharmaceutical Review

For example, the relaxed attitude towards cannabis in the Netherlands is well-known and Portugal has decriminalised the possession and consumption of all illicit substances since 2001. She has specialist expertise in patent litigation across both the telecommunications sector as well as pharmaceutical innovator and biosimilar sectors.

article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

4,6 Five patent issues that European biosimilar developers should consider before entering the US market Quality control of the botanical drug substances was one of the critical factors that led to barricades during the development of Veregen and Mytesi. 13 Currently, over 350 herbal remedies have been granted a THR licence. 2012/1916).